Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Min Na Narodnata OtbranafiledCriticalMin Na Narodnata Otbrana
Priority to BG8947189ApriorityCriticalpatent/BG48881A1/en
Publication of BG48881A1publicationCriticalpatent/BG48881A1/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Peptides Or Proteins
(AREA)
Abstract
The secreted monoclonal antibodies are applied in express immunodiagnostic tests. The antibodies are highly specific and enhance significantly the specificity and sensitivity of the immunodiagnostic tests for the proof of the diseases such as tick-spotted fever, caused by the virus Rickettsia conorii.The hybridoma cellular line is registered under NBIMCC under No. 1574 and is derived via the classical hybridoma technique.
BG8947189A1989-08-041989-08-04Hybridomic cell line mus musculus h 5/9, secretizing monoclonal antibodies against rickettsia conorii
BG48881A1
(en)
Monoclonal antibodies involved in alzheimer's disease,hybridomas secreting these monoclonal antibodies,antigen recognized by these antibodies,and their application
HIBRIDOMA CELL LINE, MUTANTS, ANTIBODIES, PROCESS FOR THE PREPARATION OF A HIBRIDOMA CELL LINE, PROCESS FOR THE PREPARATION OF ANTIBODIES, PROCESS AND AGENT FOR THE IMMUNOLOGICAL PROOF OF METHOLOLOROUS, DERIVED FROM METHOLLICATION